VERACYTE, INC. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by VERACYTE, INC. on March 2, 2020, covering an event that occurred on February 25, 2020. The company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC under the symbol VCYT.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance and compensation matters rather than financial performance data.
Material Changes
The primary material change reported is the approval of a new corporate bonus plan for the 2020 fiscal year by the independent members of the Board of Directors on February 25, 2020.
Management Commentary and Plan Details
- 2020 Bonus Plan: The plan provides annual incentive compensation for eligible employees, including executive officers.
- Performance Metrics: Awards are based on the achievement of specified corporate goals related to revenue, genomic test volume, cash flow from operations, and product development.
- Executive Payout Structure: For executive officers, the bonus pool funding can range from 0% to 140% of target amounts.
- Determination: Actual awards may exceed or fall below targets based on corporate and individual performance as determined by the Compensation Committee.
Investor Verification Checklist
- Verify the specific corporate goals and weightings for revenue, genomic test volume, cash flow, and product development in the 2020 Bonus Plan.
- Review the Compensation Committee's criteria for determining individual performance metrics for executive officers.
- Confirm the total size of the bonus pool and the specific target amounts for executive officers.
- Check subsequent filings for the actual payout percentages realized under the 0% to 140% range.